Localization and cell association of C1q in Alzheimer's disease brain

Experimental Neurology

Volumn 138, Issue 1, 1996, Pages 22-32

  Afagh, Arman ^a   Cummings, Brian J ^a   Cribbs, David H ^a   Cotman, Carl W ^a   Tenner, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT COMPONENT C1Q;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0029932195     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0043     Document Type: Article

References (66)

1. AKIYAMA, H., AND P. L. MCGEER. 1990. Brain microglia constitutively express B-2 integrins. J. Neuroimmunol. 30: 81-93.
2. BARNUM, S. R. 1993. Biosynthesis and Regulation of Complement by Cells of the Central Nervous System. In Complement Today (J. M. Cruse and R. E. Lewis, Jr., Eds.), pp. 76-95. Karger, Basel.
3. BEHL, C., J. B. DAVIS, R. LESLEY, AND D. SCHUBERT. 1994. Hydrogen peroxide mediates Amyloid β protein toxicity. Cell 77: 817-827.
4. BENSA, J. C., A. REBOUL, AND M. G. COLOMB. 1983. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 216: 385-392.
5. BRAAK, E., H. BRAAK, AND E.-M. MANDELKOW. 1994. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87: 554-567.
6. BRACHOVA, L., L. LUE, J. SCHULTZ, T. E. RASHIDY, AND J. ROGERS. 1993. Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Mol. Brain Res. 18: 329-334.
7. BREITNER, J. C. S., B. A. GAU, K. A. WELSH, B. L. PLASSMAN, W. M. MCDONALD, M. J. HELMS, AND J. C. ANTHONY. 1994. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44: 227-231.
8. BREITNER, J. C. S., K. A. WELSH, M. J. HELMS, P. C. GASKELL, B. A. GAU, A. D. ROSES, M. A. PERICAK-VANCE, AND A. M. SAUNDERS. 1995. Delayed onset of Alzheimer's Disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 4: 523-530.
9. COLTON, C. A., AND D. L. GILBERT. 1993. Microglia, an in vivo source of reactive oxygen species in the brain. Adv. Neurol. 59: 321-326.
10. COOPER, N. R. 1985. The Classical Complement Pathway: Activation and Regulation of the First Complement Component. Adv. Immunol. 37: 151-216.
11. CUMMINGS, B. J., E. HEAD, W. RUEHL, N. W. MILGRAM, AND C. W. COTMAN. 1996. The Canine as an Animal Model of Human Aging and Dementia. Neurobiol. Aging, in press.
12. CUMMINGS, B. J., J. H. SU, C. W. COTMAN, R. WHITE, AND M. J. RUSSELL. 1993. β-Amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14: 547-560.
13. CUMMINGS, B. J., J. H. SU, J. W. GEDDES, W. E. VAN NOSTRAND, S. L. WAGNER, D. D. CUNNINGHAM, AND C. W. COTMAN. 1992. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's Disease. Neuroscience 4: 763-777.
14. DICKSON, D. W., J. FARLO, P. DAVIES, H. CRYSTAL, P. FULD, AND S. C. YEN. 1988. Alzheimer's Disease: A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 1: 86-101.
15. DICKSON, D. W., S. C. LEE, L. A. MATTIACE, S. C. YEN, AND C. BROSNAN. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83.
16. EIKELENBOOM, P., C. E. HACK, W. KAMPHORST, AND J. M. ROZEMULLER. 1995. Distribution pattern and functional state of complement proteins and α1-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease. 45th Forum in Immunology, pp. 617-620.
17. EIKELENBOOM, P., C. E. HACK, J. M. ROZEMULLER, AND F. C. STAM. 1989. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B 56: 259-262.
18. EIKELENBOOM, P., J. M. ROZENMULLER, G. KRAAL, F. C. STAM, P. A. MCBRIDE, M. E. BRUCE, AND H. FRASER. 1991. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B 60: 329-336.
19. EIKELENBOOM, P., AND F. C. STAM. 1982. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol. 57: 239-242.
20. FRACKOWIAK, J., H. M. WISNIEWSKI, J. WEGIEL, G. S. MERZ, K. IQBAL, AND K. C. WANG. 1992. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce B-amyloid fibrils. Acta Neuropathol. 84: 225-233.
21. FRAUTSCHY, S. A., G. M. COLE, AND A. BAIRD. 1992. Phagocytosis and deposition of vascular B-amyloid in rat brains injected with Alzheimer B-amyloid. Am. J. Pathol. 140: 1389-1399.
22. FROLICH, L., J. KORNHUBER, R. IHL, J. FRITZE, K. MAURER, AND P. RIEDERER. 1991. Integrity of the blood-CSF barrier in dementia of Alzheimer type: Csf/serum ratios of albumin and IgG. Eur. Arch. Psy. Clin. Neurosci. 240: 363-366.
23. GALLIN, J. I. 1993. Inflammation. In Fundamental Immunology (W. E. Paul, Ed.), pp. 1015-1032. Raven Press, New York.
24. GIULIAN, D., AND T. J. BAKER. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6: 2163-2178.
25. GOODMAN, E. B., AND A. J. TENNER. 1992. Signal transduction mechanisms of C1q-mediated superoxide production: Evidence for the involvement of temporally distinct stauosporine insensitive and sensitive pathways. J. Immunol. 148: 3920-3928.
26. GRIFFIN, W. S. T., J. G. SHENG, G. W. ROBERTS, AND R. E. MRAK. 1995. Interleukin-1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evolution. J. Neuropathol. Exp. Neurol. 2: 276-281.
27. GUAN, E., S. L. ROBINSON, E. B. GOODMAN, AND A. J. TENNER 1994. Cell surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152: 4005-4016.
28. HAGA, S., K. IKEDA, M. SATO, AND T. ISHII. 1993. Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601: 88-94.
29. ISHII, T., AND S. HAGA. 1984. Immuno-electron-microscopic localization of complement in amyloid fibrils of senile plaques. Acta Neuropathol. 63: 296-300.
30. JENKINSON, M. L., M. R. BLISS, A. T. BRAIN, AND D. L. SCOTT. 1989. Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br. J. Rheumatol. 28: 86-88.
31. JIANG, H., D. BURDICK, C. G. GLABE, C. W. COTMAN, AND A. J. TENNER. 1994. β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152: 5050-5059.
32. JOHNSON, S. A., M. LAMPERT-ETCHELLS, G. M. PASINETTI, I. ROZOVSKY, AND C. FINCH. 1992. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13: 641-648.
33. KALARIA, R. N., AND G. PERRY. 1993. Amyloid P component and other acute-phase proteins associated with cerebellar AB-deposits in Alzheimer 's disease. Brain Res. 631: 151-155.
34. KITAMOTO, T., K. OGOMORI, J. TATEISHI, AND S. B. PRUSINER. 1987. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 2: 230-236. [Abstract]
35. KOROTZER, A. R., J. WATT, D. CRIBBS, A. J. TENNER, D. BURDICK, C. GLABE, AND C. W. COTMAN. 1995. Cultured rat microglia express C1q and receptor for C1q: Implications for amyloid effects on microglia. Exp. Neurol. 134: 214-221.
36. LAMPERT-ETCHELLS, M., G. M. PASINETTI, C. E. FINCH, AND S. A. JOHNSON. 1993. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration 2: 111-121.
37. LEE, S. C., W. LIU, D. W. DICKSON, C. F. BROSNAN, AND J. W. BERMAN. 1993. Cytokine production by human fetal microglia and astrocytes. J. Immunol. 150: 2659-2667.
38. LEVI-STRAUSS, M., AND M. MALLAT. 1987. Primary cultures of murine astrocytes produce C3 and Factor B, two components of the alternative pathway of complement activation. J. Immunol. 139: 2361-2366.
39. MACHKENZIE, I. R. A. 1994. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol. 87: 520-525.
40. MCGEER, P. L., H. AKIYAMA, S. ITAGAKI, AND E. G. MCGEER. 1989. Immune System response in Alzheimer's Disease. Can. J. Neurol. Sci. 16: 516-527.
41. MCGEER, P. L., T. KAWAMATA, D. G. WALKER, H. AKIYAMA, I. TOOYAMA, AND E. MCGEER. 1993. Microglia in degenerative neurological disease. Glia 7: 84-92.
42. MCGEER, P. L., E. MCGEER, J. ROGERS, AND J. SIBLEY. 1990. Anti-inflammatory drugs and Alzheimer disease. Lancet 335: 1037.
43. MCGEER, P. L., AND E. G. MCGEER. 1992. Complement proteins and complement inhibitors in Alzheimer's disease. Res. Immunol. 143: 621-624.
44. MCGEER, P. L., AND J. ROGERS. 1992. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42: 447-449.
45. MEDA, L., M. A. CASSATELLA, G. I. SZENDREL, L. OTVOS JR, P. BARON, M. VILLALBA, D. FERRARI, AND F. ROSSI. 1995. Activation of microglial cells by β-amyloid protein and interferon-gamma. Nature 374: 647-650.
46. MILLER, D. L., I. A. PAPYANNOPOULOS, J. STYLES, S. BOBIN, Y. LIN, K. BIEMANN, AND K. IQBAL. 1993. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits in Alzheimer's Disease. Arch. Biochem. Biophys. 301: 41-52.
47. MIRRA, S. S., A. HEYMAN, D. MCKEEL, S. M. SUMI, B. J. CRAIN, L. M. BROWNLEE, F. S. VOGEL, J. P. HUGHES, G. VAN BELLE, AND L. BERG. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
48. MULLER, W., H. HANAUSKI-ABEL, AND M. LOOS. 1978. Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: Evidence for an independent production of the C1 subunits. J. Immunol. 121: 1578-1584.
49. MULLER-EBERHARD, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57: 321-347.
50. NADLER, J. V., B. W. PERRY, C. GENTRY, AND C. W. COTMAN. 1980. Degeneration of Hippocampal CA3 Pyramidal Cells Induced by Intraventricular Kainic Acid. J. Comp. Neurol. 192: 333-359.
51. NAKAJIMA, K., M. SHIMOJO, M. HAMANOUE, S. ISHIURA, H. SUGITA, AND S. KOHSAKA. 1992. Identification of elastase as a secretory protease from cultured rat microglia. J. Neurochem. 58: 1401-1408.
52. PASINETTI, G. M., S. A. JOHNSON, I. ROZOVSKY, M. LAMPERT-ETCHELLS, D. G. MORGAN, M. N. GORDON, T. E. MORGAN, D. WILLOUGHBY, AND C. E. FINCH. 1992. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118: 117-125.
53. PERLMUTTER, L. S., AND M. M. DIZ. 1994. Identification of plaque cofactors in non-demented and AD Brain. Neurobiol. Aging 15: S52.
54. PERRY, V. H., P.-B. ANDERSSON, AND S. GORDON. 1993. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16: 268-273.
55. PERRY, V. H., AND S. GORDON. 1991. Macrophages and the Nervous System. Int. Rev. Cytol. 125: 203-244.
56. PIKE, C. J., B. J. CUMMINGS, R. MONZAVI, AND C. W. COTMAN. 1994. β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 2: 517-531.
57. ROGERS, J., N. R. COOPER, S. WEBSTER, J. SCHULTZ, P. L. MCGEER, S. D. STYREN, W. H. CIVIN, L. BRACHOVA, B. BRADT, P. WARD, AND I. LIEBERBURG. 1992. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89: 10016-10020.
58. ROGERS, J., J. SCHULTZ, L. BRACHOVA, L.-F. LUE, S. WEBSTER, B. BRADT, N. R. COOPER, AND D. E. MOSS. 1992. Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease. Res. Immunol. 143: 624-630.
59. SELKOE, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
60. SHIGEMATSU, K., P. L. MCGEER, D. G. WALKER, T. ISHII, AND E. G. MCGEER. 1992. Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J. Neurosci. Res. 31: 443-453.
61. SMITH, M. E. 1993. Phagocytosis of myelin by microglia in vitro. J. Neurosci. Res. 35: 480-487.
62. SU, J. H., B. J. CUMMINGS, AND C. W. COTMAN. 1994. Early phosphorylation of tau in Alzheimer's Disease occurs at Ser-202 and is preferentially located within neurites. NeuroReport 5: 2358-2362.
63. TENNER, A. J. 1993. Functional Aspects of the C1q receptors. Behring Inst. Mitt. 93: 241-253.
64. TENNER, A. J., AND D. B. VOLKIN. 1986. Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. Biochem. J. 233: 451-458.
65. YAO, J., L. HARVATH, D. L. GILBERT, AND C. A. COLTON. 1990. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27: 36-42.
66. YAO, J., J. E. KERI, R. E. TAFFS, AND C. A. COLTON. 1992. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591: 88-93.